RecruitingPhase 1NCT06813118

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

A RCT Comparing the Effectiveness of a Combination Therapy of Lezra and Clomid Versus Lezra Alone for Inducing Ovulation in Women Diagnosed With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome


Sponsor

HITEC-Institute of Medical Sciences

Enrollment

42 participants

Start Date

Jun 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Clomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickness will be checked by transvaginal ultrasound and results will be recorded.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 40 Years

Inclusion Criteria1

  • women of 20-40 years with a history of PCOS and resistant to CC

Exclusion Criteria4

  • Premature ovarian insufficiency
  • Husband has oligo azoospermia
  • Hypothyroidism
  • Hyperprolactinemia

Interventions

DRUGClomiphene Citrate and letrozole

clomiphene citrate 100mg once daily along with letrozole 5mg to one group and letrozole 5mg to second group


Locations(1)

HIT Hospital

Rawalpindi, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06813118


Related Trials